SEARCH

SEARCH BY CITATION

References

  • 1
    Bergstrand H. Uber die akute and chronische gelbe Leberatrophie mit besonderer Berucksichtigung ihres epidemischen Auftretens in Schweden in Jahre 1927. Leipzig: Georg Thieme Verlag, 1927.
  • 2
    Blomfield AL. The natural history of chronic hepatitis (cirrhosis of the liver). Am J Med Sci 1938; 195: 429431.
  • 3
    Bianchi P, Bianchi-Porro G, Coltorti M, Dardanoni L, Del Vecchio Blanco C, Fagiolo V, Farini R, et al. Occurrence of Australia antigen in chronic hepatitis in Italy. Gastroenterology 1972; 63: 482485.
  • 4
    Giusti G, Ruggiero G, Galanti B, Piccinino F, Nardiello S, Russo M, Galante D, et al. Etiological, clinical, and laboratory data of a series of chronic liver diseases from a Southern Italy area. Acta Hepato-Gastroenterol 1978; 25: 431437.
  • 5
    Smedile A, Lavarini C, Farci P, Verme G, Caredda F, Cargnel A, Caporaso N, et al. Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in Italy. Am J Epidemiol 1983; 117: 223229.
  • 6
    Colombo M, Kuo G, Choo QL, Donato MF, Del Ninno E, Tomasini MA, Dioguardi N, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 2: 10061008.
  • 7
    Gaeta GB, Rapicetta M, Sardaro C, Spadaro A, Chionne P, Freni AM, Ajello A, et al. Prevalence of anti-HCV antibodies in patients with chronic liver disease and its relationship to HBV and HDV infections. Infection 1990; 18: 277279.
  • 8
    Craxì A, Almasio P, Di Marco V, Magrin S, Bruno R, Cammà C, Fiorentino G, et al. Hepatitis C virus antibodies in chronic liver diseases of different etiology. Ital J Gastroenterol 1991; 33: 244248.
  • 9
    Esteban JI, Esteban R, Viladomiu L, Lopez-Talavera JG, Gonzales A, Hernandez JM, Roget M, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2: 294297.
  • 10
    Pares A, Bonera JM, Caballeria J. Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology 1990; 12: 12951299.
  • 11
    Gaeta GB, Giusti G. Epidemiology of chronic viral hepatitis in the Mediterranean area: present status and trends. Infection 1990; 18: 2125.
  • 12
    Giusti G, Galanti B, Gaeta GB, Piccinino F, Ruggiero G. HBsAg carriers among blood donors in Italy: a retrospective survey of data from 189 blood banks. Hepato-Gastroenterology 1981; 28: 9698.
  • 13
    Pasquini P, Kahn HA, Pileggi D, Panà A, Terzi J, Guzzanti E. Prevalence of hepatitis B markers in Italy. Am J Epidemiol 1983; 118: 699709.
  • 14
    D'Amelio R, Matricardi PM, Biselli R, Stroffolini T, Mele A, Spada E, Chionne P, et al. Changing epidemiology of hepatitis B in Italy: public health indications. Am J Epidemiol 1992; 135: 10121018.
  • 15
    Giusti G, Gaeta GB, Russo M, Bedarida G. HBsAg carriers among blood donors in Italy. A multicentre study in 107 blood banks. Infection 1989; 17: 237239.
  • 16
    Gaeta GB, De Fraia M, Sardaro C, Giusti G. HBV infection among pre-school children in Naples (Italy) and the role of intrafamily contact. Public Health 1991; 104: 331334.
  • 17
    Sagnelli E, Stroffolini T, Ascione A, Bonino F, Chiaramonte M, Colombo M, Craxì A, et al. The epidemiology of hepatitis delta infection in Italy. J Hepatol 1992; 15: 211215.
  • 18
    Sirchia G, Almini D, Bellobuono A, Giovannetti AM, Marconi M, Mercuriali F, Mozzi F, et al. Prevalence of hepatitis C virus antibodies in Italian blood donors. Vox Sang 1990; 59: 2629.
  • 19
    ISTAT. Annual for Sanitary Statistics. Rome: ISTAT, 1990: 318.
  • 20
    Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646649.
  • 21
    Greeve M, Ferrel L, Kim M, Combs C, Roberts J, Ascher N, Wright TL. Cirrhosis of undefined pathogenesis: absence of evidence for unknown viruses or autoimmune processes. Hepatology 1993; 17: 593598.
  • 22
    Stroffolini T, Chiaramonte M, Craxì A. Baseline seroepidemiology of hepatitis B virus infection in children and teenagers in Italy. J Infect 1991; 22: 191199.
  • 23
    Chiaramonte M, Stroffolini T, Caporaso N, Coppola R, Craxì A, Gaeta GB, Sagnelli E, et al. Hepatitis C virus infection in Italy: a multicentric seroepidemiological study. Ital J Gastroenterol 1991; 23: 555558.
  • 24
    Giusti G, Pasquale G, Galante D, Russo M, Sardaro C, Gallo C, Gaeta GB. Clinical and histological aspects of chronic HCV infection and cirrhosis. Hepato-Gastroenterol 1993; 40: 365369.
  • 25
    Brillanti S, Barbara L, Miglioli M, Bonino F. Hepatitis C virus: a possible cause of chronic hepatitis in alcoholics. Lancet 1989; 2: 13901391.
  • 26
    Zorski JP, Thelu MA, Moulin C, Rachail M, Seigneurin JM. Interest of the detection of hepatitis C virus RNA in patients with alcoholic liver disease. J Hepatol 1993; 17: 1014.
  • 27
    Mendenhall C, Seeff L, Diehl AM, Chosn SJ, French S, Gartside PS, Rouster SD, et al. Antibodies to hepatitis B virus and hepatitis C virus in alcoholic hepatitis and cirrhosis: their prevalence and clinical relevance. Hepatology 1991; 14: 581589.
  • 28
    Freni AM, Ajello A, Resta ML, Gaeta GB, Spadaro A, Fava A, Calapristi I, et al. HCV infection, hepatic HLA display and composition of the mononuclear cell inflammatory infiltrate in chronic alcoholic liver diseases. Eur J Clin Invest 1991; 21: 586591.
  • 29
    Alter MJ, Coleman PJ, Alexander WJ, Kramer E, Miller JK, Mandel E, Hadler SC, et al. Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA 1989; 262: 12011205.
  • 30
    Bruix J, Barrera JM, Calvet X, Guadalupe E, Costa J, Sanchez-Tapias JM, Ventura M, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; 2: 10041006.
  • 31
    Kaklamani E, Trichopoulos D, Tzonou A, Zavitsano SX, Koumantaki Y, Hatzakis A, Hsieh CC, et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991; 265: 19741976.
  • 32
    Stroffolini T, Chiaramonte M, Tiribelli C, Villa E, Simonetti RG, Rapicetta M, Stazi MA, et al. Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy. J Hepatol 1992; 16: 360363.
  • 33
    Nishioka K, Watanabe J, Furuta S, Tanaka E, Iino S, Suzuki H, Tsuji T, et al. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer 1991; 67: 429433.
  • 34
    Bosch FX, Muñoz N. Hepatocellular carcinoma in the world: epidemiologic questions. In: TaborE, Di BisceglieAM, PurcellRH, eds. Etiology, pathology and treatment of hepatocellular carcinoma in North America. Houston: Gulf Publishing, 1991: 3554.